The importance of collecting structured clinical information on multiple sclerosis.

The importance of collecting structured clinical information on multiple sclerosis.

Item
http://www.wikidata.org/entity/Q42747344
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachRationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodFingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis.Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA.To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the question.The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records.Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.Management of multiple sclerosis patients in central European countries: current needs and potential solutions.[Real-world evidence : Benefits and limitations in multiple sclerosis research].
P2860

The importance of collecting structured clinical information on multiple sclerosis.

Item
http://www.wikidata.org/entity/Q42747344
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The importance of collecting structured clinical information on multiple sclerosis.
@en
The importance of collecting structured clinical information on multiple sclerosis.
@nl
type
label
The importance of collecting structured clinical information on multiple sclerosis.
@en
The importance of collecting structured clinical information on multiple sclerosis.
@nl
prefLabel
The importance of collecting structured clinical information on multiple sclerosis.
@en
The importance of collecting structured clinical information on multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P6179
P698
P921
P932
P356
P1433
P1476
The importance of collecting structured clinical information on multiple sclerosis.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P6179
P698
P921
P932